(Hypertension. 1997;30:1169-1174.)
© 1997 American Heart Association, Inc.
Articles |
From the Laboratoire de Pharmacologie Cardio-vasculaire, Faculté de Pharmacie de l'Université Henri Poincaré, Nancy I, Nancy (N.N., V.M., I.L.-I., J.A.), and INSERM U14, Plateau de Brabois, 54511 Vandoeuvre-lès-Nancy (C.D., R.P.), France.
Correspondence to Jeffrey Atkinson, Laboratoire de Pharmacologie Cardio-vasculaire, Faculté de Pharmacie de l'Université Henri Poincaré, Nancy I, 5 rue Albert Lebrun, 54000 Nancy, France. E-mail atkinson{at}pharma.u-nancy.fr
| Abstract |
|---|
|
|
|---|
Key Words: vasodilators hypotension rats aortic stiffness
| Introduction |
|---|
|
|
|---|
In this article, we examine the effects of sodium nitroprusside, nifedipine, and hydralazine on central aortic systolic pressure, wall stiffness, and the pulse pressure (PP) contour in normotensive, nonanesthetized, unrestrained rats. Static aortic isobaric elasticity was evaluated from the slope, relating thoraco-abdominal PWV to central aortic mean blood pressure,10 11 12 13 following a drug-induced decrease in blood pressure from normotension (120 mm Hg) to 80 mm Hg. Changes in the viscoelastic properties of the aortic wall were evaluated from changes in dynamic aortic isobaric elasticity (PWV versus central aortic pulse pressure) during drug-induced hypotension. We use the term "isobaric elasticity" in the same sense as "elastic modulus," ie, an increase in isobaric elasticity denotes an increase in wall stiffness. The timing and amplitude of wave reflection were evaluated according to the method described by Murgo et al.14
| Methods |
|---|
|
|
|---|
Baseline Aortic Blood Pressure, PWV, and Wave Reflection in
Nonanesthetized, Unrestrained Rats
This technique has been described in detail
elsewhere.10 11 12 13 Polyethylene cannulas were introduced with
rats under halo-thane/oxygen anesthesia into the
descending thoracic aorta (central aortic blood pressure) and abdominal
aorta (peripheral aortic blood pressure) (systolic,
diastolic, mean, and pulse; mm Hg). A femoral
venous cannula was implanted for drug infusion. Animals were allowed 24
hours to recover, during which time food and water consumption were not
significantly different than before instrumentation.
Twenty-four hours later, the aortic cannulas were filled with
heparinized, gas-free 0.15 mol · L-1 NaCl and
connected to low-volume pressure transducers (Baxter, Bentley
Laboratories Europe). The dynamic frequency response15 of
the whole system (cannula filled with gas-free saline
solution+transducer+amplifier) was flat up to 15 Hz and then slightly
underdamped from 15 to 30 Hz (maximal value+15±2% at 30 Hz). Phase
lag was slightly different from 0 at 30 Hz (-6.2±0.6%). In a
separate experiment (n=60 observations) following recording of
the pressure waveforms with rats under anesthesia with the
cannula systems, the cannula systems were removed and replaced by
Millar Mikro-tip transducers (0.67 mm outside diameter, SPR 407,
Millar Instruments), and pressure recording was repeated. In
one half of the animals, the order was reversed (Millar then cannula).
Pressure waveforms were very similar (Fig 1
), and wave reflection
parameters were not significantly different (results not
shown).
|
Signals were amplified, converted into digital form, and recorded at a sampling rate of 256 Hz (approximately 40 sampling points per pressure wave) by a computer (PC 4-486-66/L, Dell Computer). An algorithm detected the minimum (diastolic) and maximum (systolic) of each waveform and calculated mean pressure on the basis of the area under the waveform. Pulse amplification (peripheral/central PP) was calculated. Heart rate (beats per minute) was determined by counting the number of pressure cycles. Transit times between the two pressure signals were determined by a second algorithm that shifted the peripheral signal in time with respect to the central signal and determined the value of the time shift, giving the highest correlation between the two signals.10 13 Measurements were performed for 4-second periods (approximately 26 heartbeats and 3 respiratory cycles), repeated once per minute during 15 minutes, and averaged. PWV (cm · s-1) was calculated as the distance between the two cannula tips divided by the transit time. The distance between the two cannula tips was determined in situ after postmortem dissection. A damp cotton thread was stuck onto the aorta between the tips of the two cannulas, which were marked on the thread. The thread was then removed and laid straight for measurement of the distance between the two marks (8.8±0.1 cm or 19.5±0.2 cm · kg-1, n=24).
Wave reflections were measured on the central pressure signal only. All
pressure waveforms were of type A as defined by Murgo et
al.14 The inflection point of the reflected wave was
detected by simple inspection, and the following parameters
were calculated (Fig 1
): (1) the height from the shoulder of the
reflected wave to the systolic peak (
P,
mm Hg) and (2) the augmentation index is the ratio (%) of
P to PP. The latter is an estimate of the intensity of
wave reflection. The travel time of the reflected wave (time from the
foot of the pressure wave to the shoulder
[
tp, milliseconds]) and the left
ventricular ejection time (time from the foot of the
pressure wave to the diastolic incisura; left ventricular
ejection time [LVET], milliseconds) were also measured. The effective
reflection site distance (Lp, cm) was calculated
as PWVxtp/2.14 At baseline, the
PWV measurement was used; at 100 and 80 mm Hg, PWV was
calculated from the linear regression of PWV versus central aortic mean
blood pressure (see below). The time resolution of the wave reflection
parameters was equal to the speed of data acquisition (3.9
milliseconds). Because
tp varied between 14
and 19 milliseconds, the error was 21% to 28%.
Aortic Isobaric Elasticity and Wave Reflection in
Nonanesthetized, Unrestrained Rats After Drug-Induced
Hypotension
After baseline measurements had been made, rats were infused
with sodium nitroprusside (2.3 mmol · L-1),
nifedipine (1.5 mmol · L-1), or
hydralazine (152 mmol · L-1). Central
aortic mean blood pressure was lowered from baseline (120 mm
Hg) to 80 mm Hg by stepwise (six steps) increases in infusion
rate. After each increase in volume, aortic blood pressure fell rapidly
and then stabilized. The total duration and mean dose of infusion were
for sodium nitroprusside 24±2 and 107, nifedipine 29±2
and 107, and hydralazine 23±2 minutes and 8090
nmol · kg-1 · min-1, respectively.
Infusion rates were chosen on the basis of preliminary experiments in
which at least three rates (n=6 animals per rate) for each drug were
tested (results not shown). Animals received a total blood volume of
4%. At each step, 15 measurements (
400 heartbeats) were performed.
PWV was expressed as a function of central aortic mean blood pressure
or central aortic PP (Fig 2
). Slopes
andintercepts were treated as independent parametric
variables and averaged (technique based on Gosling et
al16 17 and Kawasaki et al18 ). Wave
reflections were measured at central mean aortic pressures of 100 and
80 mm Hg.
|
Substances Used
Sodium nitroprusside, nifedipine, and
hydralazine were purchased from Sigma Chemical Co.
Nitroprusside and hydralazine were dissolved in
phosphate-buffered distilled water (10
mmol · L-1, pH 7.4, at 25°C; Sigma).
Nifedipine was dissolved in the same phosphate buffer
(50%) plus 40% polyoxyethylene glycol 400 (Coopération
Pharmaceutique Française) and 10% absolute ethanol (Farmitalia
Carlo Erba). Controls received the nifedipine solvent.
Statistics
Each variable showed a continuous unimodal distribution
(results not shown). Values are given as mean±SEM. Linear ANOVA was
performed using standard techniques, and results are expressed as slope
and intercept. Differences were evaluated by ANOVA plus the
Scheffé test. A value of P<.05 was chosen as
indicative of statistical significance.
| Results |
|---|
|
|
|---|
|
|
Each drug was administered at a dose producing a fall in central and
peripheral aortic mean blood pressures of -28% to -34%
(Table 2
compared with Table 1
). Falls in
diastolic blood pressure were of the same order and similar
in the three groups. Drugs (especially hydralazine) induced a
proportionally smaller fall in central aortic systolic
pressure, and hence pulse amplification decreased.
|
Slopes and intercepts relating PWV to central aortic mean blood
pressure were similar in all three groups; the slope relating PWV to
central aortic pulse pressure was less steep after hydralazine
(Table 3
, Fig 2
).
|
The reflected wave inflection point was undetectable in 8%, 4%, and
12% of the pressure signals studied at 120, 100, and 80 mm
Hg, respectively. None of the three vasodilators modified the timing
(
tp) of wave reflection (Table 4
). LVET tended to decrease as reflex
tachycardia developed (Table 2
). Pulse pressure increased
markedly after hydralazine. Augmentation index increased after
sodium nitroprusside. The effective reflection site distance was
similar in all groups and at all pressures.
| Discussion |
|---|
|
|
|---|
Wave Reflection and Reflection Site Distance
Any conclusion on a species-specific drug effect on wave
reflection depends on an accurate determination of the inflection point
of the reflected wave. Although the dynamic frequency response of our
system was reasonably good up to the 4th or the 5th harmonic, one could
wonder whether such a system can accurately record the rising limb
of the waveform that has high harmonic components. We think that this
is the case because recordings made using Millar Mikro-tip
transducers showed a very similar waveform with a clear inflection on
the rising limb. This is at odds with curves shown by
others19 in rats of similar size and species, where there
was little or no evidence of systolic inflection. This point
merits further investigation. In our results, the calculated effective
reflection site distance places the site of wave reflection at 4 to 5
cm from the recorded site, ie, at the level of the renal arteries.
This is interesting because some authors have suggested that in humans,
the aorta tapers at this point, thereby producing a reflection
site.20 We examined this possibility in the rat using in
situ fixation under pressure. Although there was a decrease in both
internal diameter (1.79±0.04 to 0.89±0.02 mm, n=5,
P<.05) and medial thickness (88±2 to 57±1 µm,
P<.05, unpublished results) from the 1st (just below the
left carotid artery ostium) to the 8th (iliac bifurcation site) cm of
the aorta, changes were gradual, and there was no evidence of any
abrupt change in either parameter at the 5th or 6th cm.
There was, however, an abrupt fall in the amount of the
elastin-specific amino acids, desmosine and isodesmosine, at this level
(from 503±51 in the thoracic aorta to 341±27
µg · g-1 wet wt at the 6th cm, P<.05;
unpublished results, Marque et al, 1996). This can probably be
interpreted as an abrupt change in the wall elastin content and in wall
stiffness at this point. Such a change could constitute a reflection
site.
Speed of the Wave Reflection
It is paradoxical that the reflected wave was not slowed down
despite the decrease in PWV. It is possible that the precision of the
method (3.9 milliseconds for a time of 14 to 19 milliseconds) was not
sufficient to allow small changes in the timing of wave reflection to
be detected. When timing (
tp) was expressed
as a percentage of LVET, it tended to increase (from 27±3% to 36±4%
and 34±4%, from 25±2% to 26±2% and 27±1%, and from 26±2% to
32±3% and 28±2%, in sodium nitroprusside, nifedipine,
and hydralazine groups, from baseline to 100 and 80
mm Hg, respectively). This result is consistent with a
reduction in PWV. However, it could also be explained by a reduction in
LVET following reflex tachycardia. Whatever the mechanism,
the increase in
tp/LVET does not prevent the
reflected wave adding to the incident wave in the systolic part
of the pressure waveform, thereby increasing left
ventricular end-systolic pressure.
It is possible that the structure of the arterial network in the rat, especially the short effective reflection site distance, is such that the wave is reflected extremely quickly under baseline conditions; therefore, it is impossible to significantly reduce the timing of wave reflection. The rat, even at a very young age when presumably aortic wall elasticity is at its highest,2 has a central pressure waveform of type A as defined by Murgo et al14 (reflected wave in the early part of the systole and/or augmentation index >12%).
Lack of a Specific Drug Effect on Static Aortic Isobaric
Elasticity
Over the mean blood pressure range of 120 to 80 mm Hg,
static aortic isobaric elasticity was similar whatever the vasodilator
used, suggesting that in the rat at least, all three drugs increased
static aortic elasticity by a simple reduction of intraluminal
distending pressure. These results are in contrast to those of Safar et
al,4 who showed in the brachial artery of humans that
after a similar reduction in systemic mean arterial blood
pressure elicited by infusion of nitroglycerin,
nifedipine, or dihydralazine, arterial
diameter decreased in parallel with pressure in the case of
dihydralazine, whereas it increased as pressure fell with
nitroglycerin and nifedipine. This was
associated with greater improvement of arterial elasticity
after nitroglycerin and nifedipine infusion
than after dihydralazine infusion. They concluded that nitrates
and calcium entry blockers increase elasticity by a local decrease in
smooth muscle cell tone of the arterial wall6
in addition to a reduction in intraluminal pressure. Similar results
have been obtained in a large-order branch artery of the
coronary bed in conscious dogs.21 Coronary
arterial diameter increased despite a concomitant reduction
in mean blood pressure after nitroglycerin
administration, implying once again that localized vasodilation can
occur and that this decrease in smooth muscle cell tone could lead to a
pressure-independent decrease in wall stiffness. These studies and our
own were acute; therefore, possible differences in structural effects
can be ruled out. Measurements were performed at stable aortic mean
blood pressure values; thus, in all studies wall elastic conditions
were presumably stable. The doses we used (sodium nitroprusside, 0.8;
nifedipine, 1.1; and hydralazine, 16.5
mg · kg-1) were greater than those used by Safar et
al4 (nitrates, 0.3; calcium entry-blockers, 0.4; and
dihydralazine, 0.3 mg · kg-1) or Vatner et
al21 (nitroglycerin, 25
µg · kg-1). Thus, the use of doses that were too low
in our experiments can also be ruled out.
A more plausible explanation may reside in the type of artery studied. We measured PWV along the aorta (thoracic and abdominal), which is a less muscular, more elastic artery than either the brachial or the coronary. The elastin/smooth muscle ratio in the thoracic aorta (0.87) is approximately twice that found in the coronary artery (0.44).22 23 Our results confirm those of van Gorp et al.24 In the thoracic aorta, they showed that infusion of methoxamine produced parallel increases in diastolic aortic blood pressure (from 105 to 145 mm Hg) and end-diastolic aortic diameter and a decrease in absolute wall distension, suggesting that changes in local smooth muscle tone do not modify aortic wall elasticity. Other reports also suggest that smooth muscle cells do not participate in determining aortic wall elasticity under normotensive or hypotensive conditions.25 26 In the latter studies, activation of smooth muscle cells did modify aortic elastic properties but only at aortic pressures >130 mm Hg.
In the above paragraph, it is assumed that in situations where arterial diameter does not passively follow intraluminal pressure, local smooth muscle tone changes, and this modifies elasticity. However, if diameter were to increase (after acute administration of vasodilator), then wall stress would increase, and this would increase wall stiffness.27 It could also be argued that if a specific vasodilator were to relax the aortic smooth muscle cell,5 this event would not necessarily change diameter2 but would transfer wall strain to elastin fibers.28
Intraluminal Pressure as the Main Determinant of Aortic
Stiffness
In light of these remarks, we suggest that the three vasodilators
used had similar effects on aortic elasticity and that this is linked
to their effects on intraluminal pressure. The hypothesis that this is
caused by peripheral vasodilation and that the drugs have
no direct effect on aortic smooth muscle tone can only be tested by
direct measurement of aortic diameter by echo-tracking. However, other
observations suggest that intraluminal pressure is the main determinant
of aortic elasticity, as suggested by Nichols and
O'Rourke.2 7 8 Thus, in this experiment, the values for
static aortic isobaric elasticity obtained in nonanesthetized,
unrestrained rats after a decrease in aortic mean blood pressure
elicited by infusion of vasodilators were similar to those obtained in
the pithed rat following a phenylephrine-evoked increase in
aortic blood pressure (3.3 to 4.110 11 12 13 ), although the
mechanisms used to vary aortic blood pressure were very different. The
values for static aortic isobaric elasticity obtained in these latter
studies (and in the present one) were slightly lower than those
that we reported in our first publication on this method (5.7±0.7
cm · s-1 · mm
Hg-1).11 This difference may be explained by
the fact that carotid-femoral PWV was measured in the study by Makki et
al11 instead of thoraco-abdominal aortic PWV, as was done
in the present study and others. The carotid and femoral arteries
have higher pulse wave velocities than the aorta.1
Furthermore, in awake sheep in which mean aortic blood pressure was
modified by infusion of norepinephrine,
angiotensin II, or sodium nitroprusside,29 the
calculated aortic isobaric elasticity was 4
cm · s-1 · mm Hg-1, a value
very similar to that reported here.
In conclusion, in rats as in humans, sodium nitroprusside and nifedipine had a more beneficial effect on central systolic aortic blood pressure (and presumably on end-systolic stress) than did hydralazine. The mechanism involved is probably different in the two species. In humans, it has been proposed that certain drugs (such as nitrates) attenuate the effects of wave reflection with a reduction in augmentation index. In rats, none of the drugs reduced augmentation index. The differences between the effects of the vasodilators on central systolic aortic blood pressure in the rat are not related to their effect on static isobaric elasticity but may be related to their specific effects on stroke volume19 30 31 and/or dynamic isobaric elasticity. These latter possibilities remain to be further investigated.
| Acknowledgments |
|---|
Received December 16, 1996; first decision January 15, 1997; accepted April 24, 1997.
| References |
|---|
|
|
|---|
2. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. London: Edward Arnold; 1990:398-437.
3. Nichols WW, O'Rourke MF, Avolio AP, Yaginuma T, Murgo JP, Pepine CJ, Conti CR. Effects of age on ventricular-vascular coupling. Am J Cardiol.. 1985;55:1179-1184.[Medline] [Order article via Infotrieve]
4. Safar ME, Toto-Moukouo JJ, Bouthier JA, Asmar RE, Levenson JA, Simon AC, London GM. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation. 1987;75(suppl 1):I-156-I-161.
5. Safar ME. Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens.. 1989;7:769-776.[Medline] [Order article via Infotrieve]
6. Safar ME, Bouthier JA, Levenson JA, Simon AC. Peripheral large arteries and the response to antihypertensive treatment. Hypertension. 1983;5(suppl 3):63-68.
7. O'Rourke MF, Kelly R, Avolio A. The Arterial Pulse. Philadelphia, Pa: Lea & Febiger; 1992.
8.
O'Rourke M. Arterial stiffness,
systolic blood pressure, and logical treatment of
arterial hypertension. Hypertension.. 1990;15:339-347.
9. Mitchell GF, Pfeffer MA, Pfeffer JM. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Hypertension.. 1991;18:417. Abstract.
10.
Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P,
Duvivier C, Peslin R, Atkinson J. Calcification of medial
elastic fibers and aortic elasticity. Hypertension.. 1997;29:999-1006.
11. Makki T, Tatchum-Talom R, Niederhoffer N, Amin F, Tankosic P, Mertès PM, Atkinson J. Increased arterial distensibility induced by the angiotensin-converting enzyme inhibitor, lisinopril, in normotensive rats. Br J Pharmacol.. 1994;111:555-560.[Medline] [Order article via Infotrieve]
12.
Tatchum-Talom R, Niederhoffer N, Amin F, Makki T,
Tankosic P, Atkinson J. Aortic stiffness and left
ventricular mass in a rat model of isolated
systolic hypertension. Hypertension.. 1995;26:963-970.
13.
Amin F, Niederhoffer N, Tatchum-Talom R, Makki T,
Guillou J, Tankosic P, Atkinson J. A new technique for study of
impact of arterial elasticity on left
ventricular mass in rats. Am J
Physiol.. 1996;270:H981-H987.
14.
Murgo JP, Westerhof N, Giolma JP, Altobelli SA.
Aortic input impedance in normal man: relationship to pressure
wave forms. Circulation.. 1980;62:105-116.
15. Peslin R, Fredberg JJ. Oscillation mechanics of the respiratory system. In: Macklem PT, Meads J, eds. Handbook of Physiology, Section 3, Vol III: Mechanics of breathing. Bethesda: American Physiological Society; 1986:145-177.
16. Laogun AA, Gosling RG. In vivo arterial compliance in man. Clin Phys Physiol Meas.. 1982;3:201-212.[Medline] [Order article via Infotrieve]
17. Lehmann ED, Hopkins KD, Gosling RG. Aortic compliance measurements using Doppler ultrasound: in vivo biochemical correlates. Ultrasound Med Biol.. 1993;19:683-710.[Medline] [Order article via Infotrieve]
18. Kawasaki T, Sasayama S, Yagi SI, Asakawa T, Hirai T. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res.. 1987;21:678-687.[Medline] [Order article via Infotrieve]
19.
Mitchell GF, Pfeffer MA, Westerhof N, Pfeffer JM.
Measurement of aortic input impedance in rats.
Am J Physiol.. 1994;267:H1907-H1915.
20.
Latham RD, Westerhof N, Sipkema P, Rubal BJ, Reuderink
P, Murgo JP. Regional wave travel and reflections along the
human aorta: a study with six simultaneous micromanometric
pressures. Circulation.. 1985;72:1257-1269.
21. Vatner SF, Pagani M, Manders T, Pasipoularides AD. Alpha adrenergic vasoconstriction and nitroglycerin vasodilation of large coronary arteries in the conscious dog. J Clin Invest.. 1980;65:5-14.
22.
Apter J. Correlation of visco-elastic properties
of large arteries with microscopic structure. Circ
Res.. 1966;19:104-121.
23.
Fischer GM, Llaurado JG. Collagen and elastin
content in canine arteries selected from functionally different
vascular beds. Circ Res.. 1966;19:394-399.
24.
Van Gorp AD, van Ingen-Schenau DS, Willigers J, Hoeks
APG, De Mey JGR, Struyker-Boudier HAJ, Reneman RS. A
technique to assess aortic distensibility and compliance in
anesthetized and awake rats. Am J
Physiol.. 1996;270:H780-H786.
25.
Barra JG, Armentano RL, Levenson J, Cabrera-Fischer EI,
Pichel RH, Simon A. Assessment of smooth muscle contribution to
descending thoracic aortic elastic mechanics in conscious dogs.
Circ Res.. 1993;73:1040-1050.
26.
Armentano RL, Barra JG, Levenson J, Simon A, Pichel RH.
Arterial wall mechanics in conscious dogs:
assessment of viscous, inertial, and elastic moduli to characterize
aortic wall behavior. Circ Res.. 1995;76:468-478.
27. Hayoz D, Nussberger J, Waeber B, Brunner HR. The renin-angiotensin system and arterial wall behavior. J Cardiovasc Pharmacol. 1993;22(suppl 5):S48-S52.
28. Dobrin PB, Rovick AA. Influence of vascular smooth muscle on contractile mechanics and elasticity of arteries. Am J Physiol.. 1969;217:1644-1651.
29.
Adamson SL, Whiteley KJ, Langille BL. Pressure
wave propagation and input impedance in thoracic aorta of conscious
newborn sheep. Am J Physiol.. 1995;268:H558-H568.
30. Saxena PR, Bolt GE. Haemodynamic profiles of vasodilators in experimental hypertension. Trends Pharmacol Sci. 1986;501-506.
31. Frohlich ED, Sasaki O, Chien Y, Arita M. Changes in cardiovascular mass, left ventricular pumping ability and aortic distensibility after calcium antagonists in Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens.. 1992;10:1369-1378.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
E. Cosson, M. Herisse, D. Laude, F. Thomas, P. Valensi, J.-R. Attali, M. E. Safar, and H. Dabire Aortic stiffness and pulse pressure amplification in Wistar-Kyoto and spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2506 - H2512. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gaillard, D. Casellas, C. Seguin-Devaux, H. Schohn, M. Dauca, J. Atkinson, and I. Lartaud Pioglitazone Improves Aortic Wall Elasticity in a Rat Model of Elastocalcinotic Arteriosclerosis Hypertension, August 1, 2005; 46(2): 372 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cantini, P. Kieffer, B. Corman, P. Liminana, J. Atkinson, and I. Lartaud-Idjouadiene Aminoguanidine and Aortic Wall Mechanics, Structure, and Composition in Aged Rats Hypertension, October 1, 2001; 38(4): 943 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fitch, R. Vergona, M. E. Sullivan, and Y.-X. Wang Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats Cardiovasc Res, August 1, 2001; 51(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Marque, P. Kieffer, B. Gayraud, I. Lartaud-Idjouadiene, F. Ramirez, and J. Atkinson Aortic Wall Mechanics and Composition in a Transgenic Mouse Model of Marfan Syndrome Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1184 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Niederhoffer, P. Kieffer, D. Desplanches, I. Lartaud-Idjouadiene, M.-H. Sornay, and J. Atkinson Physical Exercise, Aortic Blood Pressure, and Aortic Wall Elasticity and Composition in Rats Hypertension, April 1, 2000; 35(4): 919 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Marque, P. Kieffer, J. Atkinson, and I. Lartaud-Idjouadiene Elastic Properties and Composition of the Aortic Wall in Old Spontaneously Hypertensive Rats Hypertension, September 1, 1999; 34(3): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |